找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Biomarkers in Inflammatory Bowel Diseases; Nik Sheng Ding,Peter De Cruz Textbook 2019 Springer Nature Switzerland AG 2019 Inflammatory Bow

[复制链接]
查看: 55511|回复: 55
发表于 2025-3-21 19:00:10 | 显示全部楼层 |阅读模式
期刊全称Biomarkers in Inflammatory Bowel Diseases
影响因子2023Nik Sheng Ding,Peter De Cruz
视频video
发行地址Incorporates current biomarkers within practical algorithms that can be applied to clinical practice.Addresses predictive (early or ultra early) biomarkers of response to current therapeutic agents wh
图书封面Titlebook: Biomarkers in Inflammatory Bowel Diseases;  Nik Sheng Ding,Peter De Cruz Textbook 2019 Springer Nature Switzerland AG 2019 Inflammatory Bow
影响因子.This book provides a comprehensive and complete overview of biomarkers in clinical practice for inflammatory bowel disease (IBD) bringing together the literature in a clear and concise manner. The book bridges the gap between growing knowledge at the bench and current and future applications of biomarkers in clinical practice. .The central structure of the book focuses on prognostic and predictive biomarkers in IBD with an emphasis on the fields of research and scientific techniques (genomics, proteomics and metabonomics) that have led to biomarker discovery and places these biomarkers within a clinical context to help understand their utility in clinical practice..This book will be of use to clinicians who have an interest in using biomarkers in clinical practice as well as clinician researchers and scientists involved in the biomarker research pipeline..The author team comprises experts from around the world in order to bring together the literature in an effort to inform clinicians and researchers about the current state-of-the art in biomarker discovery.  It is intended to  assist future research efforts and indicate how biomarkers might be best applied to clinical practice bo
Pindex Textbook 2019
The information of publication is updating

书目名称Biomarkers in Inflammatory Bowel Diseases影响因子(影响力)




书目名称Biomarkers in Inflammatory Bowel Diseases影响因子(影响力)学科排名




书目名称Biomarkers in Inflammatory Bowel Diseases网络公开度




书目名称Biomarkers in Inflammatory Bowel Diseases网络公开度学科排名




书目名称Biomarkers in Inflammatory Bowel Diseases被引频次




书目名称Biomarkers in Inflammatory Bowel Diseases被引频次学科排名




书目名称Biomarkers in Inflammatory Bowel Diseases年度引用




书目名称Biomarkers in Inflammatory Bowel Diseases年度引用学科排名




书目名称Biomarkers in Inflammatory Bowel Diseases读者反馈




书目名称Biomarkers in Inflammatory Bowel Diseases读者反馈学科排名




单选投票, 共有 0 人参与投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用户组没有投票权限
发表于 2025-3-21 23:28:09 | 显示全部楼层
发表于 2025-3-22 01:09:05 | 显示全部楼层
Clinical Trial Design to Facilitate Biomarker Discoveryent would be valuable. Data and materials collected in clinical trials are a valuable source for identification of predictive biomarkers or development of pharmacokinetic models. By using a dashboard system with an incorporated pharmacokinetic model, the exact medication dose a patient should receiv
发表于 2025-3-22 04:39:53 | 显示全部楼层
Luminal Crohn’s Diseasertreating those with symptoms unrelated to their CD..Therefore, in addition to assessing clinical symptoms, there is a need to incorporate more objective markers of disease activity into the management of CD. In the pursuit of providing such information, a number of tools have been assessed in their
发表于 2025-3-22 12:01:26 | 显示全部楼层
发表于 2025-3-22 16:48:03 | 显示全部楼层
发表于 2025-3-22 20:58:46 | 显示全部楼层
Refractory Proctitisst of the other potential topical agents is limited to open-labelled studies alone and thus requires a great deal more investigation. The use of systemic, immunomodulatory and biological agents in proctitis is the same as for left-sided and extensive UC. Therapy has undoubtedly improved over recent
发表于 2025-3-23 00:53:25 | 显示全部楼层
The Role of Biomarkers in the Ileal Anal Pouchlp guide clinicians. These biomarkers can help predict those that will develop pouchitis and may therefore be useful as a surveillance strategy to enable prompt treatment before symptoms of pouchitis develop..Despite their potential, no biomarker has been validated for its use in pouchitis, and the
发表于 2025-3-23 04:24:13 | 显示全部楼层
发表于 2025-3-23 07:03:33 | 显示全部楼层
https://doi.org/10.1007/978-3-642-96306-3rgical intervention in CD, compared with proximal disease extension, hospitalization, and colectomy in UC. Age at onset, disease phenotype characteristics (early disease course, behavior and localization/disease extension), smoking status, and accelerated treatment algorithms in early disease were r
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-6-28 11:14
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表